PeptideDB

GSK3β Inhibitor II 478482-75-6

GSK3β Inhibitor II 478482-75-6

CAS No.: 478482-75-6

GSK3β inhibitor II is an inhibitor (blocker/antagonist) of GSK3β. GSK3β inhibitor II may be utilized in Alzheimer's d
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

GSK3β inhibitor II is an inhibitor (blocker/antagonist) of GSK3β. GSK3β inhibitor II may be utilized in Alzheimer's disease (AD) research.

Physicochemical Properties


Molecular Formula C14H10IN3OS
Molecular Weight 395.219
Exact Mass 394.959
Elemental Analysis C, 42.55; H, 2.55; I, 32.11; N, 10.63; O, 4.05; S, 8.11
CAS # 478482-75-6
PubChem CID 6539732
Appearance White to off-white solid powder
LogP 4.028
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 5
Rotatable Bond Count 4
Heavy Atom Count 20
Complexity 304
Defined Atom Stereocenter Count 0
InChi Key ZRHRPGSSSVYBRG-UHFFFAOYSA-N
InChi Code

InChI=1S/C14H10IN3OS/c15-12-3-1-2-10(8-12)9-20-14-18-17-13(19-14)11-4-6-16-7-5-11/h1-8H,9H2
Chemical Name

Pyridine, 4-[5-[[(3-iodophenyl)methyl]thio]-1,3,4-oxadiazol-2-yl]-
Synonyms

Glycogen synthase kinase 3β inhibitor II; GSK-3 inhibitor II; KIN 001-042; KIN-001-042; KIN001-042; KIN001042; KIN 001042; KIN-001042;
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro GSK3β inhibitor II reacts ionic to Lys85, hydrogen bonds to Lys85 and Val135 residues, and correspondingly to Ile62, Phe67, Val70, Ala83, and Leu188 residues [1]. Val135 and GSK3β inhibitor II establish a hydrogen bond[1].
References

[1]. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation. J Biomol Struct Dyn. 2021 Nov;39(18):7065-7079.

Additional Infomation 2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole is an aryl sulfide.

Solubility Data


Solubility (In Vitro) DMSO : ~50 mg/mL (~126.51 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.08 mg/mL (5.26 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.5302 mL 12.6512 mL 25.3024 mL
5 mM 0.5060 mL 2.5302 mL 5.0605 mL
10 mM 0.2530 mL 1.2651 mL 2.5302 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.